AMPK activation: a therapeutic target for type 2 diabetes?
Kimberly A Coughlan, Rudy J Valentine, Neil B Ruderman, Asish K Saha Endocrinology and Diabetes, Department of Medicine, Boston University Medical Center, Boston, MA, USA Abstract: Type 2 diabetes (T2D) is a metabolic disease characterized by insulin resistance, β-cell dysfunction, and elevate...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2014-06-01
|
| Schriftenreihe: | Diabetes, Metabolic Syndrome and Obesity |
| Online-Zugang: | http://www.dovepress.com/ampk-activation-a-therapeutic-target-for-type-2-diabetes-a17323 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|